Gumusoglu, Serena Banu http://orcid.org/0000-0002-2098-388X
Chilukuri, Akanksha Sri Satya
Hing, Benjamin Wen Qing
Scroggins, Sabrina Marie
Kundu, Sreelekha
Sandgren, Jeremy Anton
Santillan, Mark Kharim
Santillan, Donna Ann
Grobe, Justin Lewis
Stevens, Hanna Elizabeth http://orcid.org/0000-0002-3906-0786
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (T32-NS007421)
U.S. Department of Health & Human Services | National Institutes of Health (3UL1TR 002537-03W1, HD089940, HD000849, RR024980, 3UL1TR002537, 3UL1TR002537, HL084207, HL134850)
American Heart Association (19IPLOI34760288, 16POST30960016, 18SCG34350001, 19IPLOI34760288, 18EIA33890055)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
March of Dimes Foundation (4-FY18-851)
Roy J. Carver Charitable Trust
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 20 July 2020
Revised: 17 December 2020
Accepted: 8 January 2021
First Online: 28 January 2021
Conflict of interest
: M.K.S., D.A.S., and J.L.G. hold patents related to AVP for the prediction and treatment of preeclampsia: US 293 #9,937,182 (April 10, 2018), EU #2,954,324 (July 31, 2019), and PCT/US2018/027152. The authors declare that they have no conflict of interest.